Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Long-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy Poland Portugal Spain
  • Safety Study of Regulatory T Cells (Treg02) in Patients After Kidney Transplant

    Recruiting

    1 1 1
    Investigated diseases:
    Germany
  • Evaluation of nandrolone decanoate treatment combined with physiotherapy and diet in elderly patients with sarcopenia

    Recruiting

    1 1 1
    Poland
  • Long-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark Germany Italy Spain
  • A study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer

    Recruiting

    1 1 1
    France Germany Italy Poland Spain
  • An exploratory study to evaluate the effect of rimonabant on hand function in patients with cervical spinal cord injury

    Recruiting

    1 1
    Investigated diseases:
    Spain
  • A study to evaluate the effect of CX11 trometamol monohydrate in patients with type 2 diabetes

    Recruiting

    Poland
  • A study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy

    Recruiting

    1 1
    Bulgaria France Poland Romania Spain
  • A study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication

    Recruiting

    1 1
    Investigated drugs:
    Belgium Czechia Romania Spain
  • A study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis

    Recruiting

    1 1
    Investigated diseases:
    Belgium France Germany Ireland Italy The Netherlands +3